Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tabitha Mahungu

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
The Journal of Antimicrobial Chemotherapy|September 13, 2008
Detection of low-frequency K103N mutants after unstructured discontinuation of efavirenz in the presence of the CYP2B6 516 TT polymorphismAna Garcia-Diaz, Chun Bong Lok, Chun Blok, et al.
The Journal of Antimicrobial Chemotherapy|January 19, 2021
Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibioticsClaire Y Mason, Tanmay Kanitkar, Charlotte J Richardson, et al.
BMC Pregnancy and Childbirth|December 3, 2013
Management of hepatitis B in pregnant women and infants: a multicentre audit from four London hospitalsGauri Godbole, Dianne Irish, Marina Basarab, et al.
Emerging Infectious Diseases|March 18, 2021
Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UKMadhumita Shrotri, Ross J Harris, Alison Rodger, et al.
Plos One|May 30, 2020
The effect of HIV status on the frequency and severity of acute respiratory illnessJames Brown, Elisha Pickett, Colette Smith, et al.
Open Forum Infectious Diseases|November 2, 2022
Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional StudyCas Isfordink, Anders Boyd, Amanda Mocroft, et al.
The Journal of Antimicrobial Chemotherapy|March 29, 2011
Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individualsAlessandro Schipani, Christoph Wyen, Tabitha Mahungu, et al.
British Journal of Clinical Pharmacology|August 30, 2022
Comparative assessment of viral dynamic models for SARS-CoV-2 for pharmacodynamic assessment in early treatment trialsAkosua A Agyeman, Tao You, Phylinda L S Chan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2020
Decline in Hepatitis C Virus (HCV) Incidence in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Progress to HCV Microelimination in the United Kingdom?Lucy J Garvey, Graham S Cooke, Colette Smith, et al.
BMJ Open Respiratory Research|August 3, 2023
Cross-sectional study evaluating the impact of SARS-CoV-2 variants on Long COVID outcomes in UK hospital survivorsAnita Saigal, Camila Nagoda Niklewicz, Sindhu Bhaarrati Naidu, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Antimicrobial Chemotherapy|September 13, 2008
Detection of low-frequency K103N mutants after unstructured discontinuation of efavirenz in the presence of the CYP2B6 516 TT polymorphismAna Garcia-Diaz, Chun Bong Lok, Chun Blok, et al.
The Journal of Antimicrobial Chemotherapy|January 19, 2021
Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibioticsClaire Y Mason, Tanmay Kanitkar, Charlotte J Richardson, et al.
BMC Pregnancy and Childbirth|December 3, 2013
Management of hepatitis B in pregnant women and infants: a multicentre audit from four London hospitalsGauri Godbole, Dianne Irish, Marina Basarab, et al.
Emerging Infectious Diseases|March 18, 2021
Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UKMadhumita Shrotri, Ross J Harris, Alison Rodger, et al.
Plos One|May 30, 2020
The effect of HIV status on the frequency and severity of acute respiratory illnessJames Brown, Elisha Pickett, Colette Smith, et al.
Open Forum Infectious Diseases|November 2, 2022
Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional StudyCas Isfordink, Anders Boyd, Amanda Mocroft, et al.
The Journal of Antimicrobial Chemotherapy|March 29, 2011
Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individualsAlessandro Schipani, Christoph Wyen, Tabitha Mahungu, et al.
British Journal of Clinical Pharmacology|August 30, 2022
Comparative assessment of viral dynamic models for SARS-CoV-2 for pharmacodynamic assessment in early treatment trialsAkosua A Agyeman, Tao You, Phylinda L S Chan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2020
Decline in Hepatitis C Virus (HCV) Incidence in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Progress to HCV Microelimination in the United Kingdom?Lucy J Garvey, Graham S Cooke, Colette Smith, et al.
BMJ Open Respiratory Research|August 3, 2023
Cross-sectional study evaluating the impact of SARS-CoV-2 variants on Long COVID outcomes in UK hospital survivorsAnita Saigal, Camila Nagoda Niklewicz, Sindhu Bhaarrati Naidu, et al.
Pageof 3